Iraq Minister of Health endorses healthcare summit
- Iraq: Sunday, January 20 - 2013 at 13:08
- PRESS RELEASE
In the past five years Iraq's pharmaceutical sector has grown 61%, with $1.2bn spent on drugs in 2012 alone. Given the lack of essential drugs available throughout the country, spend is expected to increase to $1.5bn in 2013.
The Head of the Department of Pharmacy, Jamila Zgayeir Latfa, will present Iraq's pharmaceutical roadmap and strategy at the Iraq Health Summit on March 10th and 11th in Erbil.
The initiative is endorsed by HE Dr Majeed Hamad Amin, Minister of Health of Iraq. In addition to inaugurating the platform, he is addressing an audience of more than 150 Iraqi healthcare officials.
The summit will also be attended by officials from KIMADIA-the state-run authority responsible for the import and distribution of pharmaceutical and medical equipment for all healthcare facilities in the country. KIMADIA Director General, Dr Ihsan Jaffer Ahmed, will contribute to the conversation in the capacity of a speaker and panel discussion moderator.
The two-day platform is being hosted and organised by French business information group naseba, and is the first healthcare summit in Iraq produced by an international company and endorsed by the Ministry of Health.
One of its goals is to connect the country's healthcare leaders with international companies who have the necessary expertise. Among the many international companies present at the summit is GlaxoSmithKline, whose representatives are leading a panel discussion about the improvement of vaccination practices. In addition, representatives from pharmaceutical giant Astra Zeneca are conducting an educational workshop with a special focus on improving the healthcare reality in Iraq.
"The patronage of HE Dr Amin ensures the Iraq Health Summit is aligned with the goals of the country. Through this relationship, we want to help re-establish the position of Iraq's healthcare system as a leader in the region. Improving the pharmaceutical sector is one of the key steps being taken by the Ministry of Health," explained Fabien Faure, naseba Healthcare Series Director.
Articles in this section are primarily provided directly by the companies appearing or PR agencies which are solely responsible for the content. The companies concerned may use the above content on their respective web sites provided they link back to http://www.ameinfo.com
Any opinions, advice, statements, offers or other information expressed in this section of the AMEinfo.com Web site are those of the authors and do not necessarily reflect the views of AME Info FZ LLC / 4C. AME Info FZ LLC / 4C is not responsible or liable for the content, accuracy or reliability of any material, advice, opinion or statement in this section of the AMEinfo.com Web site.